Boehringer Ingelheim Implements Titian’s Mosaic Software
News Sep 17, 2013
Titian Software has announced that Boehringer Ingelheim has implemented its Mosaic™ sample management software for the inventory management, sample tracking, and sample processing of New Biological Entities (NBE).
Now well-established as a leading provider of sample management software for small molecule compound libraries, Titian has evolved Mosaic into enterprise-wide management of biological samples, reagents and standards.
The new installation has Boehringer Ingelheim incorporating Mosaic into their protein purification, gene expression, biological lead engineering, and biological lead generation workflows within the NBE groups.
Titian CEO, Edmund Wilson said: “Drug discovery is now more challenging than ever, and so pharmaceutical, biotech and academic organizations are seeking to maximize the efficiencies of their laboratory processes. Knowing where a sample is, what its character make-up is, and what has been done to it and by whom, is an essential element in this efficiency. Mosaic’s success has been built on the premise of listening to the needs of customers in various organizations. Based on this we have developed Mosaic to cover biological applications in addition to our heartland of chemical sample management, for which we are recognized as the ‘go-to’ offering.”
Mr Wilson continued: “We are delighted to announce this project with Boehringer Ingelheim which reflects Mosaic’s success with the management of biological samples.”
Mosaic is a modular software suite, providing a range of flexible options for many different types and sizes of life science research organizations in industry and academia.
With machine learning systems now being used to determine everything from stock prices to medical diagnoses, it's never been more important to look at how they arrive at decisions. A new approach out of MIT demonstrates that the main culprit is not just the algorithms themselves, but how the data itself is collected.